Concord Asset Management (Illinois)’s Novartis NVS Stock Holding History

Concord Asset Management (Illinois)’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$8.66M	Sell	104,359 -2,143	-2%	-$178K	3%	14
2014 Q3	$8.98M	Buy	106,502 +223	+0.2%	+$18K	3.15%	14
2014 Q2	$8.61M	Sell	106,279 -1,445	-1%	-$114K	3.11%	16
2014 Q1	$8.21M	Sell	107,724 -140	-0.1%	-$10.2K	3.07%	17
2013 Q4	$7.77M	Buy	107,864 +419	+0.4%	+$29.1K	2.87%	20
2013 Q3	$7.38M	Buy	107,445 +1,255	+1%	+$83K	2.84%	22
2013 Q2	$6.73M	Buy	+106,190	New	+$6.91M	2.79%	23

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Concord Asset Management (Illinois)'s NVS Position: Q4 2014 in Review

Concord Asset Management (Illinois) reduced its Novartis (NVS) stake by 2% in Q4 2014, selling an estimated $178K and leaving 104,359 shares worth $8.66M. The position accounts for 3% of the portfolio, ranked #14.

Concord Asset Management (Illinois) first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. The position peaked at $8.98M in Q3 2014. 918 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

Concord Asset Management (Illinois) held 104,359 shares of Novartis worth $8.66M as of Q4 2014.
Concord Asset Management (Illinois) sold 2,143 Novartis shares in Q4 2014, an estimated $178K.
Novartis made up 3% of Concord Asset Management (Illinois)'s portfolio in Q4 2014, its #14 holding.
Concord Asset Management (Illinois) first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
Concord Asset Management (Illinois)'s Novartis position peaked at $8.98M in Q3 2014.
918 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Concord Asset Management (Illinois)'s 13F filing for Q4 2014, filed 26 Jan 2015.